Platelet-derived growth factor receptor alpha
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 550–696 Chain A; UniProt 769–973 | Mutation:T674I | 6T2 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;293 K;0.1M NaCl, 0.1M Tris pH 8.0, 15% PEG 4000 | Resolution 3.10 Å R-free 0.244 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 6JOI | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 5GRN Crystal structure of PDGFRA in Complex with WQ-C-159 Deposited 2016-08-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Fragment:UNP residues 550-696 and 769-973
Chain A
769–973(205 aa)
Fragment:UNP residues 550-696 and 769-973
|
Not recorded | 748 N-[2-(dimethylamino)ethyl]-N-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]pyridine-3-carboxamide × 1 CL CHLORIDE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M KCl, 20% PEG 3350, pH 7.0
|
Resolution 1.77 Å R-free 0.179 |
| 5K5X Crystal structure of human PDGFRA Deposited 2016-05-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Fragment:UNP residues 550-696,769-973
Chain A
769–973(205 aa)
Fragment:UNP residues 550-696,769-973
|
Not recorded | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1M HEPES pH7.5, 1.6M (NH4)2SO4, 0.1M NaCl
|
Resolution 2.17 Å R-free 0.224 |
| 6A32 Crystal structure of PDGFRA kinase domain mutant T674I Deposited 2018-06-14 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Mutation:T674I Mutation:T674I | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M Bis-Tris pH 5.5, 27% PEG 3350
|
Resolution 1.87 Å R-free 0.240 |
| 6JOJ Crystal structure of PDGFRA T674I in complex with crenolanib by soaking Deposited 2019-03-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Not recorded | 6T2 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine × 1 SO4 SULFATE ION × 2 CL CHLORIDE ION × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M HEPES pH6.9, 1.6M (NH4)2SO4, 0.1M NaCl
|
Resolution 2.60 Å R-free 0.233 |
| 6JOK Crystal structure of PDGFRA in complex with sunitinib by soaking Deposited 2019-03-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Not recorded | B49 N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carbo xamide × 1 CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M HEPES pH6.9, 1.6M (NH4)2SO4, 0.1M NaCl
|
Resolution 3.80 Å R-free 0.282 |
| 6JOL Crystal structure of PDGFRA in complex with imatinib by co-crystallization Deposited 2019-03-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Not recorded | STI 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1M Sodium citrate pH4.5, 20% PEG 4000
|
Resolution 1.90 Å R-free 0.236 |
| 7LBF CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 Deposited 2021-01-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric |
Chain D
1–524(524 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;The sample was gently cross-linked with 0.025% (v/v) EM-grade glutaraldehyde for 10 min at RT and quenched with 9 mM Tris pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;blot for 2.5 seconds before plunging
|
Resolution 2.80 Å |
| 7RAM Cryo-EM Structure of the HCMV gHgLgO Trimer Derived from AD169 and TR strains in complex with PDGFRalpha Deposited 2021-07-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain D
1–524(524 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;300mM NaCl and 20mM HEPES7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.43 Å |
| 8PQH PDGFRA T674I mutant kinase domain in complex with avapritinib Deposited 2023-07-11 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Mutation:T674I Mutation:T674I | 9JI Avapritinib × 1 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;10 mg/mL, 13% PEG3350, 200 mM KCl
|
Resolution 2.50 Å R-free 0.249 |
| 8PQI PDGFRA T674I mutant kinase domain in complex with avapritinib derivative 9 Deposited 2023-07-11 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Mutation:T674I Mutation:T674I | 9OO (1~{S})-~{N}-ethyl-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine × 1 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;5 mg/mL, 5% PEG3350, 200 mM KCl
|
Resolution 2.60 Å R-free 0.254 |
| 8PQJ PDGFRA wild-type kinase domain Deposited 2023-07-11 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;285.15 K;10 mg/mL, 15% PEG3350, 100 mM Bis-Tris-Propane, pH 7.5
|
Resolution 1.82 Å R-free 0.215 |
| 8PQK APO crystal structure of PDGFRA-T674I kinase domain Deposited 2023-07-11 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–696(147 aa)
Chain A
769–973(205 aa)
|
Mutation:T674I Mutation:T674I | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;10 mg/mL, 22% PEG3350, 100 mM Bis-Tris-Propane, pH 7.5
|
Resolution 2.00 Å R-free 0.222 |
| 9GZH PDGFRA-T674I in complex with covalent ponatinib derivative 19 Deposited 2024-10-04 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
550–973(424 aa)
|
Mutation:T674I | A1IRC 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-~{N}-[4-(propanoylamino)-3-(trifluoromethyl)phenyl]benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;5 mg/mL, 18% PEG3350, 100 mM KCl
|
Resolution 2.20 Å R-free 0.215 |
13 other PDB entries and 13 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | PGFRA_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 24–170; UniProt 550–696 Author chain A; PDBConstruct 171–375; UniProt 769–973 |